Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E. Brown, Behnam Badie, Xiuli Wang et al.|New England Journal of Medicine|2016Cited by 1.8k
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsXiuli Wang, Michael C. Jensen, Wen-Chung Chang et al.|Blood|2011Cited by 600
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Christine E. Brown, Robyn A. Wong et al.|Cancer Immunology Research|2019Cited by 437
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Stephen J. Forman, Cédric Dos Santos et al.|Blood|2013Cited by 373
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryotaro Nakamura|Journal for ImmunoTherapy of Cancer|2022Cited by 19